Premas Biotech Revenue and Competitors

Gurgaon, IND

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Premas Biotech's estimated annual revenue is currently $16.6M per year.(i)
  • Premas Biotech's estimated revenue per employee is $77,500

Employee Data

  • Premas Biotech has 214 Employees.(i)
  • Premas Biotech grew their employee count by 4% last year.

Premas Biotech's People

NameTitleEmail/Phone
1
Head - Global Business DevelopmentReveal Email/Phone
2
Head HRReveal Email/Phone
3
Manufacturing OfficerReveal Email/Phone
4
Senior Manufacturing Officer (Downstream Processing)Reveal Email/Phone
5
Cofounder & Managing DirectorReveal Email/Phone
6
Information Technology ManagerReveal Email/Phone
7
Assistant ManagerReveal Email/Phone
8
Assistant ManagerReveal Email/Phone
9
Manager SCMReveal Email/Phone
10
Senior Scientist Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M155-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M1068%N/AN/A
#5
$9.5M12310%N/AN/A
#6
$21.2M2738%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M2445%N/AN/A
#9
$12.5M1619%N/AN/A
#10
$20.5M2648%N/AN/A
Add Company

What Is Premas Biotech?

Premas Biotech is an established technology-driven protein research organization, providing high-quality customized services for Gene to IND for protein bio-therapeutics. Premas works with top global pharma/biotech companies and has successfully delivered 5 therapeutics into clinics. In that path, we have developed more than 650 difficult to express proteins. We are focused on technologies integrated with process development for solving critical bottlenecks in the therapeutic development process. Apart from our services, we wish to partner on the following below: a. Recombinant CRM197 platform for Polysaccharide vaccines. b. Novel Human Naïve Antibody Library: for generation of novel Mabs, scFvs, diabodies and bispecifics. Recently, Premas successfully entered the late-stage clinical trials with Oramed for the first ever human oral insulin pill. Premas Biotech is committed to offer valuable, high-tech and quality based solutions; and with our highly skilled team, technology and expertise, we have consistently and seamlessly provided high quality services to our clients.

keywords:N/A

N/A

Total Funding

214

Number of Employees

$16.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Premas Biotech News

2021-03-19 - Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose

GURUGRAM, India--(BUSINESS WIRE)--Mar 19, 2021-- Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORM ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A21435%N/A
#2
$38.2M2155%N/A
#3
$24.5M21842%N/A
#4
$16.8M21824%N/A
#5
$16.9M219-47%$16M